The Journal of Organic Chemistry
Article
chromatography (petroleum ether/ethyl acetate = 20/1) to afford 6n
(173 mg, 78%).
reaction of 4m (170 mg, 0.5 mmol), 3b (205 mg, 1.5 mmol), and
Cs2CO3 (326 mg, 1.0 mmol) in 0.5 mL of anhydrous MeCN and 2.0
mL of anhydrous toluene afforded 181 mg (76%) of 6s: mp 150−152
3-Benzyl-5-(4-chlorophenyl)-2-phenyl-6-p-tolylpyridine (6n): mp
1
1
144−146 °C; H NMR (400 MHz, CDCl3) 7.59−7.56 (m, 2H), 7.48
°C; H NMR (400 MHz, CDCl3) 7.53 (d, J = 8.4 Hz, 2H), 7.45 (s,
(s, 1H), 7.43−7.38 (m, 3H), 7.30−7.18 (m, 7H), 7.11−7.02 (m, 6H),
4.11 (s, 2H), 2.30 (s, 3H); 13C NMR (100 MHz, CDCl3) 157.7, 154.5,
140.7, 140.3, 140.1, 138.4, 137.6, 136.8, 133.1, 132.0, 130.8, 129.9,
129.2, 128.8, 128.6, 128.6, 128.5, 128.2, 128.1, 128.0, 126.3, 38.1, 21.2;
IR (KBr) 2924, 1494, 1433, 1092, 1015 cm−1; MS m/z 444 [(M − 1)+,
65], 430 (40), 57 (100); HRMS (EI) calcd for C31H24NCl 445.1597,
found 445.1595.
1H), 7.30−7.19 (m, 7H), 7.09 (d, J = 8.4 Hz, 4H), 7.03 (d, J = 8.4 Hz,
2H), 6.94 (d, J = 8.4 Hz, 2H), 4.12 (s, 2H), 3.82 (s, 3H), 2.29 (s, 3H);
13C NMR (100 MHz, CDCl3) 159.6, 157.3, 154.4, 140.8, 140.4, 138.5,
137.5, 136.9, 133.1, 132.8, 132.6, 131.8, 130.8, 130.6, 129.9, 128.8,
128.6, 128.6, 128.4, 126.3, 113.6, 55.3, 38.2, 21.2; IR (KBr) 2918,
1508, 1432, 1248, 1175, 907 cm−1; MS m/z 474 [(M − 1)+, 100], 55
(10); HRMS (EI) calcd for C32H26NOCl 475.1703, found 475.1697.
3-Benzyl-5-(4-chlorophenyl)-2-(3,4-dimethylphenyl)-6-p-tolylpyr-
idine (6t). Following the procedure for the preparation of 6n, the
reaction of 4i (169 mg, 0.5 mmol), 3b (205 mg, 1.5 mmol), and
Cs2CO3 (326 mg, 1.0 mmol) in 0.5 mL of anhydrous MeCN and 2.0
mL of anhydrous toluene afforded 173 mg (73%) of 6t: mp 140−142
3-(4-Chlorophenyl)-5-(4-methoxybenzyl)-6-phenyl-2-p-tolylpyri-
dine (6o). Following the procedure for the preparation of 6n, the
reaction of 4d (140 mg, 0.41 mmol), 3b (164 mg, 1.2 mmol), and
Cs2CO3 (261 mg, 0.8 mmol) in 0.4 mL of anhydrous MeCN and 1.6
mL of anhydrous toluene afforded 113 mg (58%) of 6o: mp 151−153
1
1
°C; H NMR (400 MHz, CDCl3) 7.60−7.56 (m, 2H), 7.46 (s, 1H),
°C; H NMR (400 MHz, CDCl3) 7.44 (s, 1H), 7.35 (s, 1H), 7.30−
7.43−7.37 (m, 3H), 7.28 (d, J = 8.4 Hz, 2H), 7.22 (d, J = 8.4 Hz, 2H),
7.10 (d, J = 8.4 Hz, 2H), 7.04−6.97 (m, 4H), 6.80 (d, J = 8.4 Hz, 2H),
4.04 (s, 2H), 3.76 (s, 3H), 2.30 (s, 3H); 13C NMR (100 MHz, CDCl3)
158.0, 157.6, 154.4, 140.6, 140.1, 138.5, 137.5, 136.8, 133.1, 133.1,
132.4, 132.3, 130.8, 129.9, 129.8, 129.3, 128.6, 128.5, 128.1, 128.0,
114.0, 55.2, 37.2, 21.2; IR (KBr) 2954, 1511, 1433, 1248, 1092, 1035
cm−1; MS m/z 474 [(M − 1)+, 15], 416 (86), 302 (100), 233 (95);
HRMS (EI) calcd for C32H26NOCl 475.1703, found 475.1706.
3-(4-Chlorobenzyl)-6-(4-fluorophenyl)-2,5-diphenylpyridine (6p).
Following the procedure for the preparation of 6n, the reaction of 4e
(101 mg, 0.29 mmol), 3a (91 mg, 0.9 mmol), and Cs2CO3 (195 mg,
0.6 mmol) in 0.3 mL of anhydrous MeCN and 1.2 mL of anhydrous
toluene afforded 97 mg (74%) of 6p: mp 133−135 °C; 1H NMR (400
MHz, CDCl3) 7.54−7.51 (m, 3H), 7.45−7.36 (m, 6H), 7.30−7.27 (m,
4H), 7.24−7.21 (m, 1H), 6.98 (d, J = 8.4 Hz, 2H), 6.90−6.85 (m,
3H), 4.08 (s, 2H); 13C NMR (100 MHz, CDCl3) 162.5 (JC−F = 245.1
Hz), 157.6, 153.7, 140.8, 140.0, 139.5, 138.6, 135.9 (JC−F = 4.1 Hz),
133.8, 131.8 (JC−F = 8.0 Hz), 130.4, 130.1, 129.5, 129.1, 128.7, 128.4,
128.3, 128.2, 127.5, 127.3, 114.8 (JC−F = 21.3 Hz), 29.7; IR (KBr)
2918, 2849, 1491, 1217, 1157, 1015, 842 cm−1; MS m/z 448 [(M −
1)+, 100], 57 (39); HRMS (EI) calcd for C30H21NFCl 449.1347,
found 449.1350.
3-Benzyl-5-(4-ethylphenyl)-2-(4-fluorophenyl)-6-p-tolylpyridine
(6q). Following the procedure for the preparation of 6n, the reaction
of 4j (164 mg, 0.5 mmol), 3c (195 mg, 1.5 mmol), and Cs2CO3 (326
mg, 1.0 mmol) in 0.5 mL of anhydrous MeCN and 2.0 mL of
anhydrous toluene afforded 183 mg (80%) of 6q: mp 160−162 °C; 1H
NMR (400 MHz, CDCl3) 7.56−7.53 (m, 3H), 7.30 (d, J = 8.0 Hz,
2H), 7.27−7.22 (m, 2H), 7.20−7.17 (m, 1H), 7.10−7.05 (m, 8H),
7.02 (d, J = 8.0 Hz, 2H), 4.08 (s, 2H), 2.63 (q, J = 7.6 Hz, 2H), 2.29
(s, 3H), 1.22 (t, J = 7.6 Hz, 3H); 13C NMR (100 MHz, CDCl3) 162.7
(JC−F = 245.4 Hz), 156.2, 154.7, 143.2, 141.1, 140.2, 137.4, 137.2,
137.1, 136.4 (JC−F = 3.2 Hz), 134.5, 131.7, 131.1 (JC−F = 8.8 Hz),
129.9, 129.4, 128.7, 128.6, 128.5, 127.8, 126.3, 115.0 (JC−F = 21.3 Hz),
38.2, 28.5, 21.2, 15.4; IR (KBr) 3027, 1602, 1508, 1433, 1224, 1156,
1016, 909 cm−1; MS m/z 456 [(M − 1)+, 100], 91 (10); HRMS (EI)
calcd for C33H28NF 457.2206, found 457.2205.
7.23 (m, 5H), 7.20−7.14 (m, 4H), 7.09−7.07 (m, 4H), 7.02 (d, J = 8.0
Hz, 2H), 4.10 (s, 2H), 2.28 (s, 6H), 2.27 (s, 3H); 13C NMR (100
MHz, CDCl3) 157.9, 154.4, 140.5, 140.5, 138.6, 137.7, 137.4, 136.9,
136.4, 136.3, 133.0, 132.8, 131.9, 130.8, 130.5, 130.0, 129.3, 128.8,
128.6, 128.5, 128.4, 126.6, 126.2, 38.2, 21.2, 19.8, 19.5; IR (KBr) 2971,
1496, 1434, 1090, 1018 cm−1; MS m/z 472 [(M − 1)+, 8], 279 (95),
167 (100), 149 (100); HRMS (EI) calcd for C33H28NCl 473.1910,
found 473.1907.
3-Benzyl-2-(3,4-dimethylphenyl)-5-(3-nitrophenyl)-6-p-tolylpyri-
dine (6u). Following the procedure for the preparation of 6n, the
reaction of 4i (133 mg, 0.4 mmol), 3j (176 mg, 1.2 mmol), and
Cs2CO3 (261 mg, 0.8 mmol) in 0.4 mL of anhydrous MeCN and 1.6
mL of anhydrous toluene afforded 157 mg (81%) of 6u: mp 87−89
1
°C; H NMR (400 MHz, CDCl3) 8.10−8.07 (m, 2H), 7.51 (s, 1H),
7.42−7.36 (m, 3H), 7.30−7.17 (m, 7H), 7.11 (d, J = 7.6 Hz, 2H), 7.02
(d, J = 7.6 Hz, 2H), 4.14 (s, 2H), 2.30 (s, 3H), 2.28 (s, 6H); 13C NMR
(100 MHz, CDCl3) 158.7, 154.6, 148.2, 141.9, 140.5, 140.3, 137.8,
137.4, 136,7, 136.4, 136.3, 135.8, 132.2, 131.6, 130.5, 130.0, 129.3,
129.0, 128.8, 128.8, 128.6, 126.5, 126.3, 124.2, 121.9, 38.1, 21.2, 19.8,
19.6; IR (KBr) 2920, 1531, 1440, 1348, 1101, 1022, 909 cm−1; MS m/
z 484 (M+, 100), 437 (36); HRMS (EI) calcd for C33H28N2O2
484.2151, found 484.2150.
5′-Benzyl-6′-(3,4-dimethylphenyl)-2′-p-tolyl-2,3′-bipyridine (6v).
Following the procedure for the preparation of 6n, the reaction of
4i (169 mg, 0.5 mmol), 3k (155 mg, 1.5 mmol), and Cs2CO3 (326 mg,
1.0 mmol) in 0.5 mL of anhydrous MeCN and 2.0 mL of anhydrous
1
toluene afforded 183 mg (83%) of 6v: mp 124−126 °C; H NMR
(400 MHz, CDCl3) 8.61 (d, J = 1.1 Hz, 1H), 7.84 (s, 1H), 7.35−7.29
(m, 5H), 7.22 (t, J = 7.2 Hz, 2H), 7.16−7.06 (m, 5H), 7.03−6.97 (m,
3H), 4.13 (s, 2H), 2.27 (s, 6H), 2.25 (s, 3H); 13C NMR (100 MHz,
CDCl3) 158.5, 158.0, 154.5, 149.5, 140.7, 140.4, 137.7, 137.4, 137.0,
136.3, 136.1, 135.4, 133.1, 131.8, 130.4, 129.8, 129.1, 128.7, 128.5,
128.3, 126.5, 126.0, 125.1, 121.6, 38.1, 21.1, 19.7, 19.4; IR (KBr) 2918,
1589, 1497, 1428, 907 cm−1; MS m/z 439 [(M − 1)+, 12], 84 (100);
HRMS (EI) calcd for C32H28N2 440.2252, found 440.2255.
3-(Cyclopropylmethyl)-2,5-diphenyl-6-p-tolylpyridine (6w). Fol-
lowing the procedure for the preparation of 6n, the reaction of 4g (134
mg, 0.49 mmol), 3a (150 mg, 1.47 mmol), and Cs2CO3 (319 mg, 0.98
mmol) in 0.5 mL of anhydrous MeCN and 2.0 mL of anhydrous
toluene afforded 127 mg (69%) of 6w: mp 92−94 °C; 1H NMR (400
MHz, CDCl3) 7.88 (s, 1H), 7.66 (d, J = 7.6 Hz, 2H), 7.52−7.47 (m,
2H), 7.43 (t, J = 7.6 Hz, 1H), 7.38−7.31 (m, 7H), 7.06 (d, J = 7.6 Hz,
2H), 2.72 (d, J = 7.2 Hz, 2H), 2.33 (s, 3H), 1.05−0.90 (m, 1H), 0.56
(q, J = 8.0 Hz, 2H), 0.20−0.17 (m, 2H); 13C NMR (100 MHz,
CDCl3) 157.1, 154.1, 140.6, 140.4, 139.5, 137.3, 137.1, 134.2, 133.2,
130.0, 129.6, 129.3, 128.4, 128.2, 128.0, 127.7, 126.9, 36.6, 21.2, 11.3,
4.9; IR (KBr) 3002, 1427, 1181, 1019, 908 cm−1; MS m/z 374 [(M −
1)+, 100], 298 (17); HRMS (EI) calcd for C28H25N 375.1987, found
375.1991.
3-Benzyl-2-(4-chlorophenyl)-5-(4-ethylphenyl)-6-p-tolylpyridine
(6r). Following the procedure for the preparation of 6n, the reaction of
4k (172 mg, 0.5 mmol), 3c (195 mg, 1.5 mmol), and Cs2CO3 (326
mg, 1.0 mmol) in 0.5 mL of anhydrous MeCN and 2.0 mL of
anhydrous toluene afforded 147 mg (62%) of 6r: mp 127−129 °C; 1H
NMR (400 MHz, CDCl3) 7.53−7.49 (m, 3H), 7.37 (d, J = 8.0 Hz,
2H), 7.30 (d, J = 8.0 Hz, 2H), 7.28−7.24 (m, 3H), 7.09−7.06 (m,
6H), 7.02 (d, J = 8.0 Hz, 2H), 4.08 (s, 2H), 2.63 (q, J = 7.2 Hz, 2H),
2.29 (s, 3H), 1.22 (t, J = 7.2 Hz, 3H); 13C NMR (100 MHz, CDCl3)
155.9, 154.8, 143.2, 141.2, 140.2, 138.8, 137.4, 137.1, 137.1, 134.7,
134.0, 131.7, 130.7, 129.9, 129.4, 128.8, 128.6, 128.5, 128.3, 127.8,
126.3, 38.2, 28.5, 21.2, 15.4; IR (KBr) 2965, 1490, 1433, 1091, 1014,
908, 834 cm−1; MS m/z 472 [(M − 1)+, 100], 57 (31); HRMS (EI)
Calcd for C33H28NCl 473.1910, found 473.1916.
3-(Cyclopropylmethyl)-6-(naphthalen-1-yl)-2,5-diphenylpyridine
(6x). Following the procedure for the preparation of 6n, the reaction
of 4h (127 mg, 0.41 mmol), 3a (125 mg, 1.23 mmol), and Cs2CO3
(267 mg, 0.82 mmol) in 0.4 mL of anhydrous MeCN and 1.6 mL of
3-Benzyl-5-(4-chlorophenyl)-2-(4-methoxyphenyl)-6-p-tolylpyri-
dine (6s). Following the procedure for the preparation of 6n, the
3763
dx.doi.org/10.1021/jo300072x | J. Org. Chem. 2012, 77, 3754−3765